SCHEDULE
Why Converge\OIST?
Converging the brightest minds in human and planetary health and sustainability to collapse distances and advance boundaries.
A unique invite only, private experience.
Unlocking Breakthrough Thinking
Where Visionaries Meet and Futures are Forged
Attend Converge\OIST 2025
Step into a transformative, global event like no other. Converge\OIST is an exclusive, invite-only experience that brings together the brightest and most influential minds from around the world-scientists, entrepreneurs, and academics-who are defining the future of biotech, deep tech, and human and planetary health.
Set on the breathtaking and storied island of Okinawa, where ancient traditions harmonize with the cutting-edge of modern innovation, Converge\OIST transcends borders and disciplines. Through a deliberate blend of structured sessions and informal exploration, Converge\OIST curates two engaging days of focused discussions and serendipitous insights ensuring that ideas flow freely and evolve effortlessly into transformative outcomes.
Featured Speakers
Asumi Ota
Asumi Ota
Partner, Design for Ventures (D4V)
Partner, Design for Ventures (D4V)
Asumi Ota co‑leads D4V’s investment and operations, guiding startups through sourcing, due diligence, and growth. Formerly at IDEO Tokyo and Nomura Securities, she blends human‑centered design and M&A advisory to support Japanese innovators. She holds an MBA from Columbia Business School and a BComm from the University of Toronto.
Asumi Ota co‑leads D4V’s investment and operations, guiding startups through sourcing, due diligence, and growth. Formerly at IDEO Tokyo and Nomura Securities, she blends human‑centered design and M&A advisory to support Japanese innovators. She holds an MBA from Columbia Business School and a BComm from the University of Toronto.
Clement Song
Clement Song
Chairman, Clement and Xinxin Foundation
Chairman, Clement and Xinxin Foundation
Clement Song invests in early‑stage technology at Sinovation Ventures while leading the Clement and Xinxin Foundation’s philanthropic efforts in education and entrepreneurship. A computer science and engineering graduate, he cofounded AiNemo and eCitySky, using strategic insights to amplify global tech impact.
Clement Song invests in early‑stage technology at Sinovation Ventures while leading the Clement and Xinxin Foundation’s philanthropic efforts in education and entrepreneurship. A computer science and engineering graduate, he cofounded AiNemo and eCitySky, using strategic insights to amplify global tech impact.
Duncan Clark
Duncan Clark
Founder & Chairman, BDA China Ltd
Founder & Chairman, BDA China Ltd
Duncan Clark founded BDA China Ltd. in 1994 after a career with Morgan Stanley in London and Hong Kong. An early advisor to China’s internet entrepreneurs, he authored Alibaba: The House That Jack Ma Built, named a Book of the Year by The Economist. He serves on the Board of Councilors at OIST.
Duncan Clark founded BDA China Ltd. in 1994 after a career with Morgan Stanley in London and Hong Kong. An early advisor to China’s internet entrepreneurs, he authored Alibaba: The House That Jack Ma Built, named a Book of the Year by The Economist. He serves on the Board of Councilors at OIST.
Prof. Eran Segal, PhD
Prof. Eran Segal, PhD
Professor, Computational and Systems Biology, The Weizmann Institute of Science
Professor, Computational and Systems Biology, The Weizmann Institute of Science
An internationally renowned leader in computational biology, spearheading the Human Phenotype Project to uncover the intricate relationships between genetics, the microbiome, and human health.
His groundbreaking work combines big data and machine learning to personalize nutrition and reveal how individual differences impact health outcomes. Professor Segal’s research is revolutionizing precision medicine and transforming approaches to well-being worldwide.
An internationally renowned leader in computational biology, spearheading the Human Phenotype Project to uncover the intricate relationships between genetics, the microbiome, and human health.
His groundbreaking work combines big data and machine learning to personalize nutrition and reveal how individual differences impact health outcomes. Professor Segal’s research is revolutionizing precision medicine and transforming approaches to well-being worldwide.
Gil Granot‑Mayer
Gil Granot‑Mayer
Executive Vice President, Technology Development & Innovation, OIST
Executive Vice President, Technology Development & Innovation, OIST
Gil Granot‑Mayer directs OIST’s efforts to translate research into real‑world applications, overseeing technology transfer, industry partnerships, and innovation programs. A lawyer with an MBA from Tel Aviv University, he previously led initiatives at Yeda R&D (Weizmann Institute). His work advances cross‑sector collaborations that accelerate entrepreneurial impact.
Gil Granot‑Mayer directs OIST’s efforts to translate research into real‑world applications, overseeing technology transfer, industry partnerships, and innovation programs. A lawyer with an MBA from Tel Aviv University, he previously led initiatives at Yeda R&D (Weizmann Institute). His work advances cross‑sector collaborations that accelerate entrepreneurial impact.
Dr. Hiroaki Kitano, PhD
Dr. Hiroaki Kitano, PhD
President/CEO of Sony AI Inc., Professor at OIST | Founder of Kitano Symbiotic Systems Project
President/CEO of Sony AI Inc., Professor at OIST | Founder of Kitano Symbiotic Systems Project
Pioneer in systems biology, artificial intelligence, and robotics, and the driving force behind the “Nobel Turing Challenge.”
Pioneer in systems biology, artificial intelligence, and robotics, and the driving force behind the “Nobel Turing Challenge.”
Dr. Jessica Schneider, PhD, MPH
Dr. Jessica Schneider, PhD, MPH
Chief Scientific Officer, Corundum Systems Biology
Chief Scientific Officer, Corundum Systems Biology
Dr. Jessica Schneider steers Corundum Systems Biology’s translational research agenda, integrating molecular biology and public health to accelerate precision health innovations. With a dual background in scientific discovery and policy (PhD and MPH), she leads multidisciplinary initiatives aimed at bridging lab breakthroughs and real‑world impact.
Dr. Jessica Schneider steers Corundum Systems Biology’s translational research agenda, integrating molecular biology and public health to accelerate precision health innovations. With a dual background in scientific discovery and policy (PhD and MPH), she leads multidisciplinary initiatives aimed at bridging lab breakthroughs and real‑world impact.
Mr. Jingo Kikukawa
Mr. Jingo Kikukawa
Director-General, Innovation and Environment Policy Bureau, Ministry of Economy, Trade and Industry (METI)
Director-General, Innovation and Environment Policy Bureau, Ministry of Economy, Trade and Industry (METI)
A visionary leader in digital transformation who integrates policy and innovation to drive advancements in AI and data-driven solutions.
His dual roles position him at the forefront of Japan’s economic and technological evolution, shaping the future of global digital industries. He spearheads Japan’s strategies to foster innovation and combat climate change as head of METI.
A visionary leader in digital transformation who integrates policy and innovation to drive advancements in AI and data-driven solutions.
His dual roles position him at the forefront of Japan’s economic and technological evolution, shaping the future of global digital industries. He spearheads Japan’s strategies to foster innovation and combat climate change as head of METI.
Dr. Joshua Schulman, PhD
Dr. Joshua Schulman, PhD
Chief Scientist, Corundum Neuroscience
Chief Scientist, Corundum Neuroscience
Dr. Joshua Schulman directs scientific strategy at Corundum Neuroscience, overseeing funded research in neurodegenerative disorders and brain‑machine interfaces. With two decades of experience in R&D, regulatory affairs, and clinical development, he translates laboratory advances into transformative neuroscience applications.
Dr. Joshua Schulman directs scientific strategy at Corundum Neuroscience, overseeing funded research in neurodegenerative disorders and brain‑machine interfaces. With two decades of experience in R&D, regulatory affairs, and clinical development, he translates laboratory advances into transformative neuroscience applications.
Dr. Jun Seita, M.D., PhD
Dr. Jun Seita, M.D., PhD
Team Leader, Medical Data Deep Learning Team, RIKEN
Team Leader, Medical Data Deep Learning Team, RIKEN
Dr. Jun Seita heads RIKEN’s Medical Data Deep Learning Team, applying AI models to predict health trajectories and inform disease prevention. His work leverages large‑scale medical datasets and advanced computational methods to drive innovations in personalized healthcare strategies.
Dr. Jun Seita heads RIKEN’s Medical Data Deep Learning Team, applying AI models to predict health trajectories and inform disease prevention. His work leverages large‑scale medical datasets and advanced computational methods to drive innovations in personalized healthcare strategies.
Prof. Keiko Kono, PhD
Prof. Keiko Kono, PhD
Assistant Professor at Membranology Unit
Assistant Professor at Membranology Unit
Prof. Kono's new research is focused on plasma membrane damage, cellular senescence, and organismal aging. A leading expert in cellular biology, specializing in the dynamics and functions of cell membranes. Her groundbreaking research explores how membranes facilitate communication, transport, and structural integrity, advancing our understanding of cellular processes and organismal aging.
Through innovative techniques, Professor Kono’s work is paving the way for new therapies targeting membrane-related diseases.
Prof. Kono's new research is focused on plasma membrane damage, cellular senescence, and organismal aging. A leading expert in cellular biology, specializing in the dynamics and functions of cell membranes. Her groundbreaking research explores how membranes facilitate communication, transport, and structural integrity, advancing our understanding of cellular processes and organismal aging.
Through innovative techniques, Professor Kono’s work is paving the way for new therapies targeting membrane-related diseases.
Koshu Kunii
Koshu Kunii
General Partner, Lifetime Ventures
General Partner, Lifetime Ventures
Koshu Kunii invests in fintech and deep‑tech startups at Lifetime Ventures, drawing on experience at IFC (World Bank Group) and global financial institutions. Raised across four continents, he brings a global perspective to emerging‑market investments and holds a master’s in international economics and finance from Johns Hopkins SAIS.
Koshu Kunii invests in fintech and deep‑tech startups at Lifetime Ventures, drawing on experience at IFC (World Bank Group) and global financial institutions. Raised across four continents, he brings a global perspective to emerging‑market investments and holds a master’s in international economics and finance from Johns Hopkins SAIS.
Lauren Ha
Lauren Ha
Associate Vice President, Technology Development & Innovation, OIST
Associate Vice President, Technology Development & Innovation, OIST
Lauren Ha shapes OIST Innovation’s strategic vision and operations, driving commercialization of discoveries to benefit Okinawa and beyond. Formerly VP of Administration at the Molecular Sciences Institute in Berkeley—where she secured NIH Center of Excellence status—she holds a BS in Biological Sciences from the University of South Carolina.
Lauren Ha shapes OIST Innovation’s strategic vision and operations, driving commercialization of discoveries to benefit Okinawa and beyond. Formerly VP of Administration at the Molecular Sciences Institute in Berkeley—where she secured NIH Center of Excellence status—she holds a BS in Biological Sciences from the University of South Carolina.
Max Ventilla
Max Ventilla
General Partner & Head of Studio, Offline Ventures; Co‑Founder & Head of Product, Alpha Studio
General Partner & Head of Studio, Offline Ventures; Co‑Founder & Head of Product, Alpha Studio
Max Ventilla leads Offline Ventures’ studio operations and co‑founded Alpha Studio to revolutionize AI‑driven product design. Formerly at Google and Dropbox, he holds an MBA from Yale and a BS in physics and mathematics, bringing deep expertise in product strategy and entrepreneurial leadership.
Max Ventilla leads Offline Ventures’ studio operations and co‑founded Alpha Studio to revolutionize AI‑driven product design. Formerly at Google and Dropbox, he holds an MBA from Yale and a BS in physics and mathematics, bringing deep expertise in product strategy and entrepreneurial leadership.
Dr. Philip Strandwitz, PhD
Dr. Philip Strandwitz, PhD
Co‑Founder & CEO, Holobiome
Co‑Founder & CEO, Holobiome
Dr. Philip Strandwitz co‑founded Holobiome to transform microbiome science into novel therapeutics for neurological and gastrointestinal disorders. With a PhD in biology from Northeastern University, he developed pioneering techniques to cultivate gut bacteria and forged partnerships to advance microbiome‑based treatments.
Dr. Philip Strandwitz co‑founded Holobiome to transform microbiome science into novel therapeutics for neurological and gastrointestinal disorders. With a PhD in biology from Northeastern University, he developed pioneering techniques to cultivate gut bacteria and forged partnerships to advance microbiome‑based treatments.
Dr. Shunichi Kasahara
Dr. Shunichi Kasahara
Research Scientist, Sony Computer Science Laboratories & OIST
Research Scientist, Sony Computer Science Laboratories & OIST
Dr. Shunichi Kasahara pioneers Cybernetic Humanity research, developing wearable and interactive systems that redefine perception and identity. Based at Sony CSL and OIST, his work explores the fusion of digital and physical realities, challenging traditional boundaries and envisioning new modes of human‑machine symbiosis.
Dr. Shunichi Kasahara pioneers Cybernetic Humanity research, developing wearable and interactive systems that redefine perception and identity. Based at Sony CSL and OIST, his work explores the fusion of digital and physical realities, challenging traditional boundaries and envisioning new modes of human‑machine symbiosis.
Shunsuke Nagao
Shunsuke Nagao
President, Corundum Convergence Institute
President, Corundum Convergence Institute
Shunsuke Nagao leads the Corundum Convergence Institute’s mission to fund high‑impact neuroscience and systems biology research through venture philanthropy. Under his guidance, CCI builds strategic partnerships and supports projects that advance preventative healthcare and personalized medicine for global benefit.
Shunsuke Nagao leads the Corundum Convergence Institute’s mission to fund high‑impact neuroscience and systems biology research through venture philanthropy. Under his guidance, CCI builds strategic partnerships and supports projects that advance preventative healthcare and personalized medicine for global benefit.
Prof. Takao Hensch, PhD
Prof. Takao Hensch, PhD
Professor of Molecular and Cellular Biology, Harvard Center for Brain Science; Prof. of Neurology, Harvard Medical School; Director of International Research Center for Neurointelligence
Professor of Molecular and Cellular Biology, Harvard Center for Brain Science; Prof. of Neurology, Harvard Medical School; Director of International Research Center for Neurointelligence
A world-renowned neuroscience expert specializing in brain development and plasticity. A 2024 Order of the Rising Sun honoree, his pioneering research explores the mechanisms that regulate critical periods of brain adaptability, shaping our understanding of learning and memory.
Professor Hensch’s work is transforming neuroscience, offering groundbreaking insights into developmental disorders and potential therapies.
A world-renowned neuroscience expert specializing in brain development and plasticity. A 2024 Order of the Rising Sun honoree, his pioneering research explores the mechanisms that regulate critical periods of brain adaptability, shaping our understanding of learning and memory.
Professor Hensch’s work is transforming neuroscience, offering groundbreaking insights into developmental disorders and potential therapies.
Tomoko Ishikura
Tomoko Ishikura
Managing Partner at Kicker Ventures
Managing Partner at Kicker Ventures
Tomoko has extensive experience across various sectors of healthcare in many different countries and business cultures.
Before founding Kicker Ventures, she served as Business Development Advisor to Nipro, worked for Axios International in France, UNICEF in Rwanda, and PwC’s PRTM and Aqumen Biopharmaceutical in Japan. Tomoko is a trained pharmacist and molecular biologist, holding an MBA from INSEAD and an MS from Kyushu University.
A strong advocate for women in venture, Tomoko is active in the U.S. female VC community, speaks at major global conferences, and mentors in leading accelerator programs — guiding the next generation of healthcare entrepreneurs and investors.
In addition to her role at Kicker Ventures, Tomoko teaches meditation classes in San Francisco and brings thoughtful and practical approaches back to her work in fostering a valuable, authentic community in the healthcare industry.
Tomoko has extensive experience across various sectors of healthcare in many different countries and business cultures.
Before founding Kicker Ventures, she served as Business Development Advisor to Nipro, worked for Axios International in France, UNICEF in Rwanda, and PwC’s PRTM and Aqumen Biopharmaceutical in Japan. Tomoko is a trained pharmacist and molecular biologist, holding an MBA from INSEAD and an MS from Kyushu University.
A strong advocate for women in venture, Tomoko is active in the U.S. female VC community, speaks at major global conferences, and mentors in leading accelerator programs — guiding the next generation of healthcare entrepreneurs and investors.
In addition to her role at Kicker Ventures, Tomoko teaches meditation classes in San Francisco and brings thoughtful and practical approaches back to her work in fostering a valuable, authentic community in the healthcare industry.
Yasushi Yamamoto
Yasushi Yamamoto
Founder & CEO, Corundum Group
Founder & CEO, Corundum Group
Yasushi Yamamoto founded the Corundum group to fuel life‑changing discoveries by partnering with researchers, entrepreneurs, and visionaries worldwide. With leadership roles at Sumitomo Corporation across multiple continents, he drives Corundum’s ventures in neurotech, microbiome, and AI to illuminate the future of humanity.
Yasushi Yamamoto founded the Corundum group to fuel life‑changing discoveries by partnering with researchers, entrepreneurs, and visionaries worldwide. With leadership roles at Sumitomo Corporation across multiple continents, he drives Corundum’s ventures in neurotech, microbiome, and AI to illuminate the future of humanity.
Okinawa delivers an unparalleled diversity of ideas, cultures, and geographies.
Shape Conversations of Global Importance
Attendees travel from all corners of the world, bringing diverse perspectives enriching the discussions and fueling innovative solutions. The journey to Okinawa is an investment, but the rewards are world-changing insights and the creation of a global community united in advancing human and planetary health.
More than just a backdrop, Okinawa is an integral component of the event. The island’s culture, traditions, and natural beauty are woven into the experience, providing an environment that goes beyond aesthetics to actively shape the flow and impact of the gathering. From the wisdom of Okinawa’s Blue Zone longevity practices to its emphasis on community and harmony with nature, elements of the island is integrated to inspire and drive transformative innovation. This holistic integration of Okinawa’s unique attributes ensures that the event is not just a conference, but a journey that ignites the creative spirit of every participant.
AGENDA
Day 1 – Monday, May 12
Systems, Science & Synergy
Kick off with a blessing, then a visionary keynote by Sony AI’s Hiroaki Kitano, followed by panels on innovation policy, phenotyping, and precision health. Includes Okinawan cultural immersion and an evening dinner experience. Ending the day with an Okinawan experience dinner.
08:00–09:30
Registration & Continental Breakfast
09:30–09:50
Welcome & Opening Blessing
10:00-11:30
The Machine Scientist: Building AI That Can Make Nobel-Worthy Discoveries — Prof. Hiroaki Kitano
10:00-11:30
The Machine Scientist: Building AI That Can Make Nobel-Worthy Discoveries — Prof. Hiroaki Kitano
10:00-11:30
The Machine Scientist: Building AI That Can Make Nobel-Worthy Discoveries — Prof. Hiroaki Kitano
10:00-11:30
The Machine Scientist: Building AI That Can Make Nobel-Worthy Discoveries — Prof. Hiroaki Kitano
13:30-14:30
Architecture of Innovation: Where Policy, Capital, and Science Collide — Jingo KIkukawa, Gil Granot-Mayer; Moderator: Lauren Ha
13:30-14:30
Architecture of Innovation: Where Policy, Capital, and Science Collide — Jingo KIkukawa, Gil Granot-Mayer; Moderator: Lauren Ha
12:00-13:30
Lunch
15:00–15:45
Cracking the Phenotype: The Next Leap in Understanding Human Health — Prof. Eran Segal
15:00–15:45
Cracking the Phenotype: The Next Leap in Understanding Human Health — Prof. Eran Segal
13:30-14:30
Architecture of Innovation: Where Policy, Capital, and Science Collide — Jingo KIkukawa, Gil Granot-Mayer; Moderator: Lauren Ha
13:30-14:30
Architecture of Innovation: Where Policy, Capital, and Science Collide — Jingo KIkukawa, Gil Granot-Mayer; Moderator: Lauren Ha
16:00–17:00
Mapping Humanity – The Future of Phenotyping & Precision Health — Prof. Eran Segal, Jun Seita, Chieko Mori; Moderator: Jessica Schneider
16:00–17:00
Mapping Humanity – The Future of Phenotyping & Precision Health — Prof. Eran Segal, Jun Seita, Chieko Mori; Moderator: Jessica Schneider
15:00–15:45
Cracking the Phenotype: The Next Leap in Understanding Human Health — Prof. Eran Segal
15:00–15:45
Cracking the Phenotype: The Next Leap in Understanding Human Health — Prof. Eran Segal
16:00–17:00
Mapping Humanity – The Future of Phenotyping & Precision Health — Prof. Eran Segal, Jun Seita, Chieko Mori; Moderator: Jessica Schneider
16:00–17:00
Mapping Humanity – The Future of Phenotyping & Precision Health — Prof. Eran Segal, Jun Seita, Chieko Mori; Moderator: Jessica Schneider
19:00–21:00
Dinner
Day 2 – Tuesday, May 13
From Longevity to Legacy
Start with sunrise meditation, then dive into neuroscience, AI, and collaborative models. Highlights include a tour of OIST, a special sweet treat, and closing panel on future projections. Wrap up with a festive dinner and Night Market at OIST.
08:00–08:50
Continental Breakfast with Okinawan Music
08:50–09:20
Creating Peace for a Joyful Life, a participatory breathing meditation session — Tomoko Ishikura
09:30–10:30
Cracks That Change Us: The Hidden Power of Cell Damage — Prof. Keiko Kono
09:30–10:30
Cracks That Change Us: The Hidden Power of Cell Damage — Prof. Keiko Kono
13:00–13:30
Cybernetic Humanity: Enabling The New Humanity Emerging From The Integration of Human And Computers — Dr. Shunichi Kasahara
13:00–13:30
Cybernetic Humanity: Enabling The New Humanity Emerging From The Integration of Human And Computers — Dr. Shunichi Kasahara
09:30–10:30
Cracks That Change Us: The Hidden Power of Cell Damage — Prof. Keiko Kono
09:30–10:30
Cracks That Change Us: The Hidden Power of Cell Damage — Prof. Keiko Kono
10:30–12:00
OIST Campus Tour
12:00–13:00
Lunch
15:30-16:15
Rewriting the Playbook – New Models for Early-Stage Innovation — Max Ventilla, Philip Strandwitz, Koshu Kunii, Moderator: Asumi Ota
15:30-16:15
Rewriting the Playbook – New Models for Early-Stage Innovation — Max Ventilla, Philip Strandwitz, Koshu Kunii, Moderator: Asumi Ota
13:00–13:30
Cybernetic Humanity: Enabling The New Humanity Emerging From The Integration of Human And Computers — Dr. Shunichi Kasahara
13:00–13:30
Cybernetic Humanity: Enabling The New Humanity Emerging From The Integration of Human And Computers — Dr. Shunichi Kasahara
13:45–15:15
Tour: Cybernetic Humanity Lab / Coffee & Tea Break
16:30–17:45
Rewiring The Mind: Expanding Neurointelligence and The Future of Human Potential — Prof. Takao Hensch, Dr. Josh Schulman; Moderator: Clement Song
16:30–17:45
Rewiring The Mind: Expanding Neurointelligence and The Future of Human Potential — Prof. Takao Hensch, Dr. Josh Schulman; Moderator: Clement Song
18:00–18:40
What Now? Reflections from the Edge of Convergence — Gil Granot-Mayer, Yasushi Yamamoto, Shunsuke Nagao; Moderator: Duncan Clark
18:00–18:40
What Now? Reflections from the Edge of Convergence — Gil Granot-Mayer, Yasushi Yamamoto, Shunsuke Nagao; Moderator: Duncan Clark
15:30-16:15
Rewriting the Playbook – New Models for Early-Stage Innovation — Max Ventilla, Philip Strandwitz, Koshu Kunii, Moderator: Asumi Ota
15:30-16:15
Rewriting the Playbook – New Models for Early-Stage Innovation — Max Ventilla, Philip Strandwitz, Koshu Kunii, Moderator: Asumi Ota
16:30–17:45
Rewiring The Mind: Expanding Neurointelligence and The Future of Human Potential — Prof. Takao Hensch, Dr. Josh Schulman; Moderator: Clement Song
16:30–17:45
Rewiring The Mind: Expanding Neurointelligence and The Future of Human Potential — Prof. Takao Hensch, Dr. Josh Schulman; Moderator: Clement Song
18:00–18:40
What Now? Reflections from the Edge of Convergence — Gil Granot-Mayer, Yasushi Yamamoto, Shunsuke Nagao; Moderator: Duncan Clark
18:00–18:40
What Now? Reflections from the Edge of Convergence — Gil Granot-Mayer, Yasushi Yamamoto, Shunsuke Nagao; Moderator: Duncan Clark
19:00–21:00
Dinner & Night Market at OIST
BUS SCHEDULE
CONVERGE SHUTTLE BUS SCHEDULE
MAY 11th
MAY 12th
MAY 13th
TIME:
18:30 - 21:35
ROUTE
Dinner
Dinner
Sheraton Sunmarina Resort
18:15
-
Rizzan Sea Park Hotel Tancha Bay
-
18:20
PST
18:50
18:50
ROUTE
Dinner
Dinner
PST
21:15
21:15
Rizzan Sea Park Hotel Tancha Bay
-
21:30
Sheraton Sunmarina Resort
21:35
-
BUS SCHEDULE
CONVERGE SHUTTLE BUS SCHEDULE
MAY 11th
MAY 12th
MAY 13th
TIME:
18:30 - 21:35
ROUTE
Dinner
Dinner
Sheraton Sunmarina Resort
18:15
-
Rizzan Sea Park Hotel Tancha Bay
-
18:20
PST
18:50
18:50
ROUTE
Dinner
Dinner
PST
21:15
21:15
Rizzan Sea Park Hotel Tancha Bay
-
21:30
Sheraton Sunmarina Resort
21:35
-
BUS SCHEDULE
CONVERGE SHUTTLE BUS SCHEDULE
MAY 11th
MAY 12th
MAY 13th
TIME:
18:30 - 21:35
ROUTE
Dinner
Dinner
Sheraton Sunmarina Resort
18:15
-
Rizzan Sea Park Hotel Tancha Bay
-
18:20
PST
18:50
18:50
ROUTE
Dinner
Dinner
PST
21:15
21:15
Rizzan Sea Park Hotel Tancha Bay
-
21:30
Sheraton Sunmarina Resort
21:35
-
BUS SCHEDULE
CONVERGE SHUTTLE BUS SCHEDULE
MAY 11th
MAY 12th
MAY 13th
TIME:
18:30 - 21:35
ROUTE
Dinner
Dinner
Sheraton Sunmarina Resort
18:15
-
Rizzan Sea Park Hotel Tancha Bay
-
18:20
PST
18:50
18:50
ROUTE
Dinner
Dinner
PST
21:15
21:15
Rizzan Sea Park Hotel Tancha Bay
-
21:30
Sheraton Sunmarina Resort
21:35
-
Our Hosts
Our Hosts
